Customer Publication

Cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids

Authors: E. Lajkó et al.

Journal: Beilstein J. Org. Chem. (2018)

Institution: Semmelweis University

Research Areas: Cancer Research

Cell Lines: A2058 (Melanoma cell line)

Summary: The article studies various peptide hormone-based derivates, in this case GnRH-R, for tumor therapy. HoloMonitor M4 was used to evaluate the effects of the derivatives on melanoma cell morphology, including cell area, thickness, eccentricity, hull convexity, and irregularity. Additionally, authors employed HoloMonitor to study cell motility, migration, and speed in order to evaluate peptide derivative ability to immobilize cells and prevent spreading and possible metastasis development.

Keywords: HoloMonitor M4, Cell migration, Cell morphology, Drug-targeting conjugates; Gonadotropin-releasing hormone-III; Holographic microscopy; Impedimetry; short-chain fatty acids

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2